(Absolute Neutrophil Count)
ANC is a blood test number that shows how many neutrophils (infection-fighting ) you have. It helps your team decide how strong your immune system is right now.
If ANC is low, you may hear '' and get extra infection precautions. A low ANC can also delay treatment until your body recovers.
Anemia means your red blood cell count is low, so your body has less oxygen to work with. It can make you feel tired, weak, dizzy, or short of breath.
During cancer treatment, anemia is common and manageable. Your team may suggest iron, medicine, dietary changes, or sometimes a blood transfusion.
(BMP)
BMP is a blood panel that checks core electrolytes plus kidney function and glucose. It is narrower than a but still very useful for treatment safety checks.
You might get BMP or CMP depending on what your team needs to monitor that week. Both help catch changes early.
CA 15-3 is a blood often used to track some breast cancers over time, especially in settings. It is more useful as a trend than as a one-time number.
Like other markers, it can rise or fall for reasons besides obvious progression. Doctors read it together with symptoms, scans, and exam findings.
CA 19-9 is a tumor marker most often linked with pancreatic and some GI cancers, but it may still come up in broad oncology bloodwork conversations.
It is not a screening test for the general population. It is mostly used to follow trends in people already being evaluated or treated.
CA 27.29 is another blood marker that may be used in breast cancer follow-up, mostly to watch trends in some advanced-disease settings.
A high or low number alone rarely decides anything. The pattern over time matters more than one isolated lab result.
CA-125 is a blood test marker often used in ovarian cancer care. It can help track how treatment is going or watch for changes over time.
It is useful, but not perfect. A CA-125 level alone cannot diagnose cancer, so doctors interpret it with scans, symptoms, and other tests.
(Complete Blood Count)
CBC is a routine blood test that checks red blood cells, white blood cells, hemoglobin, and . It is one of the most common labs during treatment.
Think of it as a quick snapshot of how your blood and bone marrow are handling things. It helps your team keep treatment safe.
(Carcinoembryonic Antigen)
CEA is a tumor marker blood test often used in some GI cancers and sometimes in broader oncology follow-up. It is usually used to track trend over time, not as a stand-alone .
Like other markers, context matters a lot. Doctors compare CEA with scans, symptoms, and physical exam.
CMP (Comprehensive Metabolic Panel)
CMP is a blood panel that checks electrolytes, kidney function, liver-related values, glucose, and protein levels. It is a common safety lab in cancer care.
Think of it as a broad systems check that helps teams spot dehydration, organ stress, and treatment effects early.
(Human Epididymis Protein 4)
HE4 is a blood marker that can be used in ovarian cancer evaluation and follow-up in some settings, often alongside CA-125.
Like all markers, it is not a stand-alone diagnosis. It is one data point interpreted with imaging, symptoms, and exam.
(Lactate Dehydrogenase)
LDH is a blood test that can reflect tissue stress or cell turnover. In oncology it can be one supporting lab among many, depending on cancer type.
An LDH value alone does not diagnose progression. It is most useful when interpreted as part of the bigger clinical picture.
(LFTs)
LFTs are blood tests that check liver-related values like AST, ALT, alkaline phosphatase, and bilirubin. These labs are commonly monitored during treatment.
Changes can happen from medications, dehydration, liver irritation, or other causes, so teams follow trends and adjust treatment if needed.
Platelets
Platelets are blood cells that help clotting and prevent bleeding. Cancer treatment can lower platelet counts.
When platelets are very low, bruising or bleeding risk goes up, and treatment may be delayed for safety.
Tumor Marker
A tumor marker is a substance in blood (or another sample) that can help track cancer activity in some cases. Examples include CA-125 and CA 15-3.
Markers are trends, not verdicts. One value alone rarely tells the full story.
White Blood Cells (WBC)
White blood cells are immune cells that help fight infection. Cancer treatment can raise or lower WBC counts.
Tracking WBC counts helps your team balance treatment effectiveness and infection safety.